These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20133028

  • 1. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
    Weber KC, Salum LB, Honório KM, Andricopulo AD, da Silva AB.
    Eur J Med Chem; 2010 Apr; 45(4):1508-14. PubMed ID: 20133028
    [Abstract] [Full Text] [Related]

  • 2. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B, Polikarpov I, Andricopulo AD.
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [Abstract] [Full Text] [Related]

  • 3. Ligand-based pharmacophore model of N-Aryl and N-Heteroaryl piperazine alpha 1A-adrenoceptors antagonists using GALAHAD.
    Zhao X, Yuan M, Huang B, Ji H, Zhu L.
    J Mol Graph Model; 2010 Sep; 29(2):126-36. PubMed ID: 20538497
    [Abstract] [Full Text] [Related]

  • 4. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N, Senkovich O, Walker K, Wright DL, Anderson AC, Rosowsky A, Ananthan S, Shinkre B, Velu S, Chattopadhyay D.
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [Abstract] [Full Text] [Related]

  • 5. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 6. A 3D QSAR study on a set of dopamine D4 receptor antagonists.
    Boström J, Böhm M, Gundertofte K, Klebe G.
    J Chem Inf Comput Sci; 2003 Oct 22; 43(3):1020-7. PubMed ID: 12767161
    [Abstract] [Full Text] [Related]

  • 7. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
    Gaillard P, Carrupt PA, Testa B, Schambel P.
    J Med Chem; 1996 Jan 05; 39(1):126-34. PubMed ID: 8568799
    [Abstract] [Full Text] [Related]

  • 8. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH, Guido RV, Oliva G, Ferreira EI, Andricopulo AD.
    J Mol Graph Model; 2009 Aug 05; 28(1):3-11. PubMed ID: 19376735
    [Abstract] [Full Text] [Related]

  • 9. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K, Lindner M, Pianwanit S, Kokpol S, Sippl W.
    Eur J Med Chem; 2009 Apr 05; 44(4):1383-95. PubMed ID: 18976834
    [Abstract] [Full Text] [Related]

  • 10. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB, Polikarpov I, Andricopulo AD.
    J Chem Inf Model; 2008 Nov 05; 48(11):2243-53. PubMed ID: 18937440
    [Abstract] [Full Text] [Related]

  • 11. [3D QSAR analysis of novel 5-HT1A receptor ligands].
    Borosy AP.
    Acta Pharm Hung; 1998 Mar 05; 68(2):71-8. PubMed ID: 9592931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors.
    Sköld C, Karlén A.
    J Mol Graph Model; 2007 Jul 05; 26(1):145-53. PubMed ID: 17161636
    [Abstract] [Full Text] [Related]

  • 15. Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptor.
    Machado A, Tejera E, Cruz-Monteagudo M, Rebelo I.
    Eur J Med Chem; 2009 Dec 05; 44(12):5045-54. PubMed ID: 19846239
    [Abstract] [Full Text] [Related]

  • 16. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G.
    J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML.
    J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
    Vermeulen ES, Schmidt AW, Sprouse JS, Wikström HV, Grol CJ.
    J Med Chem; 2003 Dec 04; 46(25):5365-74. PubMed ID: 14640545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.